The Practice and Willingness of Women Towards Opportunistic Screening for Breast and Cervical Cancers in Sichuan Province, China: A Cross-Sectional Study

References

• Sung H, Ferlay J, Siegel RL. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Lei S, Zheng R, Zhang S, et al. Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. Cancer Biol Med. 2021;18(3):900–909. doi:10.20892/j.issn.2095-3941.2020.0523
   PubMed Web of Science ®Google Scholar
• Duan R, Xu K, Huang L. Temporal trends and projection of cancer attributable to human papillomavirus infection in China, 2007–2030. Cancer Epidemiol Biomarkers Prev. 2022;31(5):1130–1136. doi:10.1158/1055-9965.EPI-21-1124
   PubMed Web of Science ®Google Scholar
• He J, Wei WQ. China Cancer Registry Annual Report 2019. 1st. Beijing: People’s Medical Publishing House; 2021.
   Google Scholar
• World Health Organization. National Cancer Control Programmes: Policies and Managerial Guidelines. 2nd. World Health Organization; 2002.
   Google Scholar
• Humphrey LL, Helfand M, Chan BK, Woolf SH. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137(5):347–360. doi:10.7326/0003-4819-137-5_part_1-200209030-00012
   PubMed Web of Science ®Google Scholar
• Jansen EEL, Zielonke N, Gini A, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207–223. doi:10.1016/j.ejca.2019.12.013
   PubMed Web of Science ®Google Scholar
• Teng Y, Cao MM, Chen WQ. 中国癌症筛查的发展、现状与挑战[Development, status and challenges of cancer screening in China]. China Cancer. 2022;31(7):481–487. Chinese
   Google Scholar
• Bao HL, Wang LH, Wang LM, et al. 中国2013年35~69岁女性人群子宫颈癌和乳腺癌筛查率及影响因素研究[Study on the coverage of cervical and breast cancer screening among women aged 35–69 years and related impact of socioeconomic factors in China, 2013]. Zhonghua liu xing bing xue za zhi. 2018;39(2):208–212. Chinese. doi:10.3760/cma.j.issn.0254-6450.2018.02.014
   PubMedGoogle Scholar
• Sun L, Sadique Z, Dos-Santos-Silva I, et al. Cost-effectiveness of breast cancer screening programme for women in rural China. Int J Cancer. 2019;144(10):2596–2604. doi:10.1002/ijc.31956
   PubMed Web of Science ®Google Scholar
• Breast Cancer Committee of Chinese Anti-Cancer Association. China anti-cancer association guidelines and norms for the diagnosis and treatment of breast cancer (2021 edition). Chin Oncol. 2021;31(8):770–856.
   Google Scholar
• Jolidon V, De Prez V, Willems B, et al. Never and under cervical cancer screening in Switzerland and Belgium: trends and inequalities. BMC Public Health. 2020;20(1):1517. doi:10.1186/s12889-020-09619-z
   PubMed Web of Science ®Google Scholar
• Zielonke N, Kregting LM, Heijnsdijk EAM. The potential of breast cancer screening in Europe. Int J Cancer. 2021;148(2):406–418. doi:10.1002/ijc.33204
   PubMed Web of Science ®Google Scholar
• Arbyn M, Rebolj M, De Kok IM, et al. The challenges of organising cervical screening programmes in the 15 old member states of the European Union. Eur J Cancer. 2009;45(15):2671–2678. doi:10.1016/j.ejca.2009.07.016
   PubMed Web of Science ®Google Scholar
• Gustafsson L, Sparén P, Gustafsson M, et al. Efficiency of organised and opportunistic cytological screening for cancer in situ of the cervix. Br J Cancer. 1995;72(2):498–505. doi:10.1038/bjc.1995.362
   PubMed Web of Science ®Google Scholar
• Vutuc C, Waldhoer T, Haidinger G. Breast cancer trends: opportunistic screening in Austria versus controlled screening in Finland and Sweden. Eur J Cancer Prev. 2006;15(4):343–346. doi:10.1097/00008469-200608000-00007
   PubMed Web of Science ®Google Scholar
• Shen SJ, Xu YL, Zhou YD, et al. 中国女性乳腺癌群体筛查与机会性筛查的比较研究[A comparative study of breast cancer mass screening and opportunistic screening in Chinese women]. Zhonghua Wai Ke Za Zhi. 2021;59(2):109–115. Chinese. doi:10.3760/cma.j.cn112139-20201015-00753
   PubMedGoogle Scholar
• Mo M, Zheng Y, Liu G, et al. 上海市女性乳腺癌有组织筛查和机会性筛查的成本效果分析上海市女性乳腺癌有组织筛查和机会性筛查的成本效果分析[Cost-effectiveness analysis of two breast cancer screening modalities in Shanghai, China]. Zhonghua zhong liu za zhi. 2015;37(12):944–951. Chinese.
   PubMedGoogle Scholar
• Zhao FH, Li LY, Li LK, et al. 中国子宫颈癌机会性筛查多中心临床研究[Multi-center studies of cervical cancer opportunistic screening in China]. Oncol Prog. 2010;8(2):109–113. Chinese.
   Google Scholar
• Wang GQ, Wei WW. 上消化道癌筛查和早诊早治项目的新转变:机会性筛查[A new transition of the screening, early diagnosis and early treatment project of the upper gastrointestinal cancer: opportunistic screening]. Zhonghua yu fang yi xue za zhi. 2019;53(11):1084–1087. Chinese. doi:10.3760/cma.j.issn.0253-9624.2019.11.002
   PubMedGoogle Scholar
• CPC Central Committee. State Council. Healthy China Action Plan; 2019. Available from: http://www.gov.cn/xinwen/2019-07/15/content_5409694.htm. Accessed January 7, 2023.
   Google Scholar
• Vallone F, Lemmo D, Martino ML, et al. Factors promoting breast, cervical and colorectal cancer screenings participation: a systematic review. Psychooncology. 2022;31(9):1435–1447. doi:10.1002/pon.5997
   PubMed Web of Science ®Google Scholar
• CPC Central Committee. State Council. The outline of the Healthy China 2030 strategy; 2016. Available from: http://www.gov.cn/zhengce/2016-10/25/content_5124174.htm. Accessed September 8, 2022.
   Google Scholar
• Borràs JM, Guillen M, Sánchez V, et al. Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain). Eur J Cancer Prev. 1999;8(5):427–434. doi:10.1097/00008469-199910000-00008
   PubMed Web of Science ®Google Scholar
• National Health and Family Planning Commission of the People’s Republic of China. New work specifications for basic public health services; 2019. Available from: http://www.nhc.gov.cn/jws/s7881/201909/83012210b4564f26a163408599072379.shtml. Accessed September 8, 2022.
   Google Scholar
• Meng Q, Mills A, Wang L, et al. What can we learn from China’s health system reform? BMJ. 2019;365:l2349. doi:10.1136/bmj.l2349
   PubMed Web of Science ®Google Scholar
• Le Bonniec A, Sun S, Andrin A, et al. Barriers and facilitators to participation in health screening: an umbrella review across conditions. Prev Sci. 2022;23(7):1115–1142. doi:10.1007/s11121-022-01388-y
   PubMed Web of Science ®Google Scholar
• Akhigbe AO, Omuemu VO. Knowledge, attitudes and practice of breast cancer screening among female health workers in a Nigerian urban city. BMC Cancer. 2009;9:203. doi:10.1186/1471-2407-9-203
   PubMed Web of Science ®Google Scholar
• Jia Y, Li S, Yang R, et al. Knowledge about cervical cancer and barriers of screening program among women in Wufeng County, a high-incidence region of cervical cancer in China. PLoS One. 2013;8(7):e67005. doi:10.1371/journal.pone.0067005
   PubMed Web of Science ®Google Scholar
• Nuche-Berenguer B, Sakellariou D. Socioeconomic determinants of participation in cancer screening in Argentina: a cross-sectional study. Front Public Health. 2021;9:699108. doi:10.3389/fpubh.2021.699108
   PubMed Web of Science ®Google Scholar
• Douglas E, Waller J, Duffy SW, et al. Socioeconomic inequalities in breast and cervical screening coverage in England: are we closing the gap? J Med Screen. 2016;23(2):98–103. doi:10.1177/0969141315600192
   PubMed Web of Science ®Google Scholar
• Wang JH, Liang W, Chen MY, et al. The influence of culture and cancer worry on colon cancer screening among older Chinese-American women. Ethn Dis. 2006;16(2):404–411.
   PubMed Web of Science ®Google Scholar
• Ivanova A, Kvalem IL. Psychological predictors of intention and avoidance of attending organized mammography screening in Norway: applying the extended parallel process model. BMC Womens Health. 2021;21(1):67. doi:10.1186/s12905-021-01201-y
   PubMed Web of Science ®Google Scholar
• Wu Z, Liu Y, Li X, et al. Factors associated with breast cancer screening participation among women in mainland China: a systematic review. BMJ open. 2019;9(8):e028705. doi:10.1136/bmjopen-2018-028705
   PubMed Web of Science ®Google Scholar
• Tian T, Di JL, Yang WL, et al. 我国3省城市和农村妇女乳腺癌知信行现况及其影响因素比较[A comparison study on status and influencing factors of knowledge, attitudes, and practice related to breast cancer among women in urban and rural areas in 3 provinces of China]. Chin J Health Educ. 2018;34(1):14–18. Chinese.
   Google Scholar
• Zhao XL, Wang Y, Liu ZH, et al. 19201名女性对宫颈癌筛查及HPV疫苗的认知情况及影响因素分析[Knowledge and its influencing factors of cervical cancer screening and human papillomavirus vaccines among 19,201 Chinese population]. Chinese J Cancer Prev Treat. 2022;29(9):623–629. Chinese.
   Google Scholar
• Ren WH, Zhao XL, Zhao FH. 全球宫颈癌筛查指南制定现状的系统综述[Global guidelines for cervical cancer screening: a systematic review]. Zhonghua Yi Xue Za Zhi. 2021;101:1882–1889. Chinese. doi:10.3760/cma.j.cn112137-20210115-00134
   PubMedGoogle Scholar
• Siu AL. Screening for breast cancer: U.S. preventive services task force recommendation statement. Ann Intern Med. 2016;164(4):279–296. doi:10.7326/M15-2886
   PubMed Web of Science ®Google Scholar
• Zhao R, Liang S, Teoh D, et al. A comprehensive cross-sectional survey to identify barriers and facilitators of cervical cancer screening in women with HIV in Guangxi, China. Infect Agent Cancer. 2022;17(1):12. doi:10.1186/s13027-022-00426-2
   PubMed Web of Science ®Google Scholar